Traws Pharma (TRAW) Free Cash Flow (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Free Cash Flow of -$2.6 million for Q1 2026, up 54.37% year-over-year from -$1.7 million in Q1 2025, and up 6.78% quarter-over-quarter from -$2.8 million in Q4 2025.
Traws Pharma (TRAW) Free Cash Flow (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Free Cash Flow for 15 consecutive years, with -$2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 54.37% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$15.3 million (up 50.59% YoY), while the FY2025 annual figure was -$20.8 million, up 37.89% from the prior year.
- Free Cash Flow climbed to -$2.6 million in Q1 2026 per TRAW's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$2.6 million in Q1 2026 and bottomed at -$11.5 million in Q3 2024.
- Historically, Free Cash Flow has averaged -$5.0 million across 5 years, with a median of -$4.4 million in 2024.
- Annual changes were most pronounced in 2024 — Free Cash Flow sank 156.79% — and 2025, when it soared 65.05%.
- Traws Pharma's Free Cash Flow stood at -$3.9 million in 2022, then fell by 14.06% to -$4.4 million in 2023, then gained by 8.8% to -$4.0 million in 2024, then jumped by 31.73% to -$2.8 million in 2025, then increased by 6.78% to -$2.6 million in 2026.
- Business Quant data shows TRAW's Free Cash Flow at -$2.6 million in Q1 2026, -$2.8 million in Q4 2025, and -$4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - | -7.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57 Mn |
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Sep 30, 2025 | -4.01 Mn |
| Sep 30, 2025 | -4.01 Mn |
| Jun 30, 2025 | -5.98 Mn |
| Jun 30, 2025 | -5.98 Mn |
| Mar 31, 2025 | -5.63 Mn |
| Mar 31, 2025 | -5.63 Mn |
| Dec 31, 2024 | -4.04 Mn |
| Dec 31, 2024 | -4.04 Mn |
| Sep 30, 2024 | -11.48 Mn |
| Sep 30, 2024 | -11.48 Mn |
| Jun 30, 2024 | -9.85 Mn |
| Jun 30, 2024 | -9.85 Mn |
| Mar 31, 2024 | -4.42 Mn |
| Mar 31, 2024 | -4.42 Mn |
| Dec 31, 2023 | -4.43 Mn |
| Dec 31, 2023 | -4.43 Mn |